Yanwei Sun Lina Pei Ningning Luo Dongsheng Chen Lingxin Meng
10.2147/OTT.S267524
Onco Targets Ther
2020 Nov 2;13:11177-11181.
egfr exon20 pt790m loss myh9-ret fusion acquired resistance lung adenocarcinoma osimertinib
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/33173309/
Case Reports
PMC7646409
33173309
A Novel MYH9-RET Fusion Occurrence and EGFR T790M Loss as an Acquired Resistance Mechanism to Osimertinib in a Patient with Lung Adenocarcinoma: A Case Report
2020